AAV-mediated FGF21 gene therapy promotes health span extension by whole-body tissue-specific adaptations

Veronica Jimenez1, Victor Sacristan1, Miquel Garcia1

  • 1Center of Animal Biotechnology and Gene Therapy (CBATEG), Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain; Department of Biochemistry and Molecular Biology, School of Veterinary Medicine, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Insights

Muscle-directed fibroblast growth factor 21 (FGF21) gene therapy in aged mice improved healthspan and lifespan. This intervention normalized body weight, enhanced organ function, and boosted cognition, offering a potential gerotherapeutic strategy.

Area of Science:

  • Aging research
  • Gene therapy
  • Metabolic diseases

Background:

  • Organ function decline limits healthspan in aging.
  • Lifestyle interventions show potential but sustained healthspan maintenance is difficult.
  • No gerotherapeutic drugs are currently approved.

Purpose of the Study:

  • To investigate the efficacy of muscle-directed adeno-associated viral (AAV) vector-mediated fibroblast growth factor 21 (FGF21) gene therapy in aged mice.
  • To assess the impact of AAV-FGF21 on healthspan, lifespan, and organ function.
  • To explore the underlying molecular mechanisms of AAV-FGF21 treatment.

Main Methods:

  • Administration of muscle-directed AAV-FGF21 gene therapy to aged and geriatric male and female mice.
  • Assessment of various physiological parameters including body weight, adiposity, insulin sensitivity, glucose homeostasis, hepatic detoxification, kidney function, cardiac health, muscle function, and cognition.
  • Transcriptomic and histopathological analyses to evaluate whole-body energy homeostasis, cellular fitness, mitochondrial function, proteostasis, inflammation, fibrosis, and amyloidosis.
  • Investigation of AMPK signaling pathway activation.

Main Results:

  • AAV-FGF21 treatment extended healthspan and lifespan in aged mice.
  • The therapy normalized body weight and adiposity, improved insulin sensitivity and glucose homeostasis.
  • Significant improvements were observed in hepatic detoxification, kidney health, cardiac function, muscle strength, and cognitive performance.
  • Transcriptomic and histopathological analyses revealed enhanced energy homeostasis and cellular fitness, with restored mitochondrial function, proteostasis, and reduced inflammation, fibrosis, and amyloidosis.
  • AMPK signaling was activated by AAV-FGF21 treatment.

Conclusions:

  • Muscle-directed FGF21 gene therapy is a promising strategy to extend healthspan and lifespan.
  • This approach effectively counteracts age-related physiological decline and improves multiple organ functions.
  • FGF21 gene therapy demonstrates potential as a gerotherapeutic intervention by improving whole-body energy homeostasis and cellular resilience.

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Whole Body Regeneration01:33

Whole Body Regeneration

Regeneration is the process of restoring injured or lost tissues, organs, or body parts. While simpler organisms generally show greater ability to regenerate their whole body, few complex animals show similarly exceptional regeneration. For example, planarian flatworms have a unique regenerative potential making them a popular study organism among biologists to understand the mechanisms of whole body regeneration. Other organisms, such as hydra, also show extreme regeneration potential; even...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...